Psychemedics Valuation

Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Psychemedics recent Real Value cannot be determined due to lack of data. The prevailing price of Psychemedics is $0.0. Our model determines the value of Psychemedics from analyzing the company fundamentals such as Operating Margin of (0.19) %, return on equity of -0.61, and Shares Outstanding of 5.89 M as well as examining its technical indicators and probability of bankruptcy.

Psychemedics Total Value Analysis

Psychemedics is at this time expected to have company total value of 14.22 M with market capitalization of 15.74 M, debt of 2.3 M, and cash on hands of 1.79 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Psychemedics fundamentals before making security assessment based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
14.22 M
15.74 M
2.3 M
1.79 M

Psychemedics Investor Information

About 23.0% of the company outstanding shares are owned by corporate insiders. The book value of Psychemedics was at this time reported as 1.15. The company recorded a loss per share of 0.51. Psychemedics last dividend was issued on the 24th of May 2023. The entity had 1:4 split on the 1st of August 2002. Based on the key indicators related to Psychemedics' liquidity, profitability, solvency, and operating efficiency, Psychemedics is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.

Psychemedics Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Psychemedics has an asset utilization ratio of 179.28 percent. This indicates that the Company is making $1.79 for each dollar of assets. An increasing asset utilization means that Psychemedics is more efficient with each dollar of assets it utilizes for everyday operations.

Psychemedics Ownership Allocation

The market capitalization of Psychemedics is $15.74 Million. Psychemedics has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.

Psychemedics Profitability Analysis

The company reported the last year's revenue of 22.1 M. Reported Net Loss for the year was (4.15 M) with profit before taxes, overhead, and interest of 9.29 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Psychemedics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Psychemedics and how it compares across the competition.

Psychemedics Growth Indicators

Investing in growth stocks can be very risky. If the company such as Psychemedics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding5.7 M
Quarterly Earnings Growth Y O Y-0.302
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Consideration for investing in Psychemedics Pink Sheet

If you are still planning to invest in Psychemedics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Psychemedics' history and understand the potential risks before investing.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios